Trials / Unknown
UnknownNCT05926609
A Study to Evaluate the Efficacy of EB-PA on Muscle Mass and Strength in Occasional Gym Goers
A Placebo-Controlled, Single-Blind Sequential Study to Evaluate the Efficacy of EB-PA on Muscle Mass and Strength in Occasional Gym Goer
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 36 (estimated)
- Sponsor
- Vedic Lifesciences Pvt. Ltd. · Industry
- Sex
- Male
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
The present study is a placebo- controlled, single-blind sequential study. Total of 40 males aged between ≥ 18 years and ≤35 years will be screened. Assuming screen failure and dropout rate in this study, a minimum of 30 participants should complete the study. The treatment duration for all the study participants will be 60 days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | EB-PA | 1 capsule to be taken after breakfast once a day |
| DIETARY_SUPPLEMENT | Placebo | 1 capsule to be taken after breakfast once a day |
Timeline
- Start date
- 2023-07-27
- Primary completion
- 2023-12-15
- Completion
- 2023-12-15
- First posted
- 2023-07-03
- Last updated
- 2023-08-24
Locations
2 sites across 1 country: India
Source: ClinicalTrials.gov record NCT05926609. Inclusion in this directory is not an endorsement.